2022
DOI: 10.1016/j.brainresbull.2022.02.011
|View full text |Cite
|
Sign up to set email alerts
|

Effect of early exercise on inflammatory parameters and apoptosis in CA1 area of the hippocampus following cerebral ischemia-reperfusion in rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

1
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 34 publications
1
2
0
Order By: Relevance
“…The results also showed that apoptotic cells in the CA1 area increased after LPS injection. This phenomenon is also consistent with many previous studies [ 30 , 36 , 53 , 54 ].…”
Section: Discussionsupporting
confidence: 94%
“…The results also showed that apoptotic cells in the CA1 area increased after LPS injection. This phenomenon is also consistent with many previous studies [ 30 , 36 , 53 , 54 ].…”
Section: Discussionsupporting
confidence: 94%
“…Transient forebrain ischemia causes neuronal damage through various mechanisms, and the most reliable cell death mechanisms are oxidative stress and inflammation in the CA1 region. Ischemia activates astrocytes and www.nature.com/scientificreports/ microglia, which release large amounts of pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-α 3,5 , and produce ROS by nicotinamide adenine dinucleotide phosphate oxidase 4 . In this study, we visualized astrocytes and microglia in the hippocampal CA1 region 4 days after ischemia induction.…”
Section: Discussionmentioning
confidence: 99%
“…Interruption of blood supply to the brain in ischemic strokes causes massive neuronal loss in the brain, including the hippocampus, resulting in severe complications and reduced quality of life 2 . Various cell death mechanisms have been proposed, including oxidative stress induced by reactive oxygen species (ROS) and neuroinflammation induced by pro-inflammatory cytokines, such as interleukin (IL)-1β, IL-6, and tumor necrosis factor-α (TNF-α) [3][4][5] . However, few therapeutics are available, except for tissue plasminogen activator, because of their low bioavailability and permeability to the blood-brain barrier.…”
mentioning
confidence: 99%